Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9

Journal of Inflammation

Volumn 6, Issue , 2009, Pages

  De Paiva, Cintia S ^a   Yoon, Kyung Chul ^a,b   Pangelinan, Solherny B ^a   Pham, Sapa ^a   Puthenparambil, Larry M ^a   Chuang, Eliseu Y ^a   Farley, William J ^a   Stern, Michael E ^c   Li, De Quan ^a   Pflugfelder, Stephen C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Chonnam National University   (South Korea)

^c ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GELATINASE B; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA EPITHELIUM; DESICCATION; DRY EYE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOREACTIVITY; LACRIMAL FLUID; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYMOGRAPHY;

MURINAE; MUS;

EID: 73149089672     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-6-31     Document Type: Article

References (50)

1. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. TA Waldmann, Nat Rev Immunol 2006 6 595 601 10.1038/nri1901 16868550
2. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. TA Waldmann S Dubois Y Tagaya, Immunity 2001 14 105 110 11239443
3. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. T Miyazaki ZJ Liu A Kawahara Y Minami K Yamada Y Tsujimoto EL Barsoumian RM Permutter T Taniguchi, Cell 1995 81 223 231 10.1016/0092-8674(95)90332-1 7736574
4. A function for interleukin 2 in Foxp3-expressing regulatory T cells. JD Fontenot JP Rasmussen MA Gavin AY Rudensky, Nat Immunol 2005 6 1142 1151 10.1038/ni1263 16227984
5. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Y Refaeli PL Van CA London J Tschopp AK Abbas, Immunity 1998 8 615 623 10.1016/S1074-7613(00)80566-X 9620682
6. The IL-2/IL-2 receptor system: a current overview. T Taniguchi Y Minami, Cell 1993 73 5 8 10.1016/0092-8674(93)90152-G 8462103
7. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. M Noguchi Y Nakamura SM Russell SF Ziegler M Tsang X Cao WJ Leonard, Science 1993 262 1877 1880 10.1126/science.8266077 8266077 (Pubitemid 24041859)
8. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. A Leonardi P Brun G Abatangelo M Plebani AG Secchi, Invest Ophthalmol Vis Sci 2003 44 3052 3058 10.1167/iovs.02-0766 12824251
9. Functional interleukin-2 receptors on intestinal epithelial cells. C Ciacci YR Mahida A Dignass M Koizumi DK Podolsky, J Clin Invest 1993 92 527 532 8326018 10.1172/JCI116598
10. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. DM Willerford J Chen JA Ferry L Davidson A Ma FW Alt, Immunity 1995 3 521 530 10.1016/1074-7613(95)90180-9 7584142
11. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. B Sadlack J Lohler H Schorle G Klebb H Haber E Sickel RJ Noelle I Horak, Eur J Immunol 1995 25 3053 3059 10.1002/eji.1830251111 7489743
12. Novel animal models for Sjogren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. R Sharma L Zheng X Guo SM Fu ST Ju WN Jarjour, J Autoimmun 2006 27 289 296 10.1016/j.jaut.2006.11.003 17207605
13. Interleukin-2 receptor expression in salivary glands of patients with Sjogren's syndrome. J Coll S Tomas R Vilella J Corominas, J Rheumatol 1995 22 1488 1491 7473471
14. Soluble interleukin-2 receptor in Sjogren's syndrome: relation to main serum immunological and immunohistochemical parameters. A Spadaro V Riccieri G Benfari M Scillone E Taccari, Clin Rheumatol 2001 20 319 323 10.1007/s100670170020 11642512
15. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjogren's syndrome and other autoimmune diseases]. S Tomas J Coll P Reth JM Corominas, Med Clin (Barc) 1998 111 681 686 9887430
16. Interleukin 2 modulates intestinal epithelial cell function in vitro. AU Dignass DK Podolsky, Exp Cell Res 1996 225 422 429 10.1006/excr.1996.0193 8660931
17. Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. O Schulz HF Sewell F Shakib, J Exp Med 1998 187 271 275 9432986 10.1084/jem.187.2.271 (Pubitemid 28060444)
18. A novel role of metalloproteinase in cancer-mediated immunosuppression. BC Sheu SM Hsu HN Ho HC Lien SC Huang RH Lin, Cancer Res 2001 61 237 242 11196168
19. Soluble interleukin-2 receptors and serum autoantibodies in dry eye patients: correlation with lacrimal gland function. K Tsubota T Fujihara T Takeuchi, Cornea 1997 16 339 344 9143809
20. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection. RK Gupta M Jain RK Sharma, Indian J Med Res 2004 119 24 27 14997990
21. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. A Leonardi F Borghesan D Faggian M Depaoli AG Secchi M Plebani, Am J Ophthalmol 2000 129 151 158 10.1016/S0002-9394(99)00295-0 10682966
22. Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. MN Manoussakis GK Papadopoulos AA Drosos HM Moutsopoulos, Clin Immunol Immunopathol 1989 50 321 332 10.1016/0090-1229(89)90140-2 2783895
23. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. DH Campen DA Horwitz FP Quismorio Jr GR Ehresmann WJ Martin, Arthritis Rheum 1988 31 1358 1364 10.1002/art. 1780311103 3263865
24. Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. EC Keystone KM Snow C Bombardier CH Chang DL Nelson LA Rubin, Arthritis Rheum 1988 31 844 849 10.1002/art.1780310704 3134896
25. Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity? NC Wood JA Symons GW Duff, J Autoimmun 1988 1 353 361 10.1016/0896-8411(88)90005-4 3266993
26. Soluble interleukin-2 receptor in primary and secondary Sjogren's syndrome. S Tomas J Coll X Palazon, Br J Rheumatol 1997 36 194 197 10.1093/rheumatology/36.2.194 9133928
27. Soluble interleukin-2 receptors in serum from patients with primary Sjogren's syndrome. M Diamant N Tvede JU Prause P Oxholm, Scand J Rheumatol 1991 20 370 372 10.3109/03009749109096814 1947901
28. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. SC Pflugfelder W Farley L Luo LZ Chen CS de Paiva LC Olmos DQ Li ME Fini, Am J Pathol 2005 166 61 71 15632000
29. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. CS de Paiva RM Corrales AL Villarreal WJ Farley DQ Li ME Stern SC Pflugfelder, Exp Eye Res 2006 83 526 535 10.1016/j.exer.2006.02.004 16643899
30. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice. AL Villareal W Farley SC Pflugfelder, Eye Contact Lens 2006 32 272 276 10.1097/01.icl.0000224360.10319.b1 17099387
31. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. RM Corrales ME Stern CS de Paiva J Welch DQ Li SC Pflugfelder, Invest Ophthalmol Vis Sci 2006 47 3293 3302 10.1167/iovs.05-1382 16877394
32. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. CS de Paiva RM Corrales AL Villarreal W Farley DQ Li ME Stern SC Pflugfelder, Invest Ophthalmol Vis Sci 2006 47 2847 2856 10.1167/iovs.05-1281 16799024
33. MMP inhibition in prostate cancer. BL Lokeshwar, Ann N Y Acad Sci 1999 878 271 289 10.1111/j.1749-6632.1999.tb07690.x 10415736
34. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. R Hanemaaijer H Visser P Koolwijk T Sorsa T Salo LM Golub VW van Hinsbergh, Adv Dent Res 1998 12 114 118 10.1177/08959374980120010301 9972133
35. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. TH Vu JM Shipley G Bergers JE Berger JA Helms D Hanahan SD Shapiro RM Senior Z Werb, Cell 1998 93 411 422 10.1016/S0092-8674(00)81169-1 9590175
36. Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress. RM Corrales A Villarreal W Farley ME Stern DQ Li SC Pflugfelder, Cornea 2007 26 579 584 17525655
37. IFN- Promotes Goblet Cell Loss in Response to Desiccating Ocular Stress. CS de Paiva AL Villarreal RM Corrales HT Rahman VY Chang JW Farley ME Stern JY Niederkorn L D-Q SC Pflugfelder, Invest Ophthalmol Vis Sci 2006 2006 47 E-Abstract 5579
38. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. L Sobrin Z Liu DC Monroy A Solomon MG Selzer BL Lokeshwar SC Pflugfelder, Invest Ophthalmol Vis Sci 2000 41 1703 1709 10845589
39. Phenotypic characterization of human corneal epithelial cells expanded ex vivo from limbal explant and single cell cultures. HS Kim SX Jun CS de Paiva Z Chen SC Pflugfelder DQ Li, Exp Eye Res 2004 79 41 49 10.1016/j.exer.2004.02.015 15183099
40. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. SE Wilson Q Li J Weng PA Barry-Lane JV Jester Q Liang RJ Wordinger, Invest Ophthalmol Vis Sci 1996 37 1582 1592 8675401
41. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. L Luo DQ Li RM Corrales SC Pflugfelder, Eye & Contact Lens 2005 31 5 186 93 10.1097/01.ICL.0000162759.79740.46 16163009
42. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. AA Afonso L Sobrin DC Monroy M Selzer B Lokeshwar SC Pflugfelder, Invest Ophthalmol Vis Sci 1999 40 2506 2512 10509643
43. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. A Leonardi P Brun G Abatangelo M Plebani AG Secchi, Invest Ophthalmol Vis Sci 2003 44 3052 3058 10.1167/iovs.02-0766 12824251
44. Active form of gelatinases in tear fluidin patients with corneal ulcer or ocular burn. T Sakimoto J Shoji M Sawa, Jpn J Ophthalmol 2003 47 423 426 10.1016/S0021-5155(03)00138-2 12967855
45. Late corneal perforation after photorefractive keratectomy associated with topical diclofenac: involvement of matrix metalloproteinases. EE Gabison P Chastang S Menashi S Mourah S Doan M Oster A Mauviel T Hoang-Xuan, Ophthalmology 2003 110 1626 1631 10.1016/S0161-6420(03)00486-X 12917183
46. Effects of topical nonsteroidal antiinflammatory drugs on the expression of matrix metalloproteinases in the cornea. VE Reviglio TS Rana QJ Li MF Ashraf MK Daly TP O'Brien, J Cataract Refract Surg 2003 29 989 997 10.1016/S0886- 3350(02)01737-6 12781288
47. Tear MMP-9 Activity in Dysfunctional Tear Syndrome. S Chotikavanich DQ Li CS de Paiva F Bian JW Farley SC Pflugfelder, Invest Ophthalmol Vis Sci 2008 49 E-Abstract 5293
48. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships. AN El Houda C Badoual S Hans A Gey B Vingert S Peyrard F Quintin-Colonna P Ravel P Bruneval S Roncelin B Lelongt J Bertoglio WH Fridman D Brasnu E Tartour, Clin Exp Immunol 2007 150 114 123 17680822
49. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. A Leonardi SJ Curnow H Zhan VL Calder, Clin Exp Allergy 2006 36 777 784 10.1111/j.1365-2222. 2006.02499.x 16776679
50. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. EB Cook JL Stahl L Lowe R Chen E Morgan J Wilson R Varro A Chan FM Graziano NP Barney, J Immunol Methods 2001 254 109 118 10.1016/S0022-1759(01)00407-0 11406157